Login / Signup

A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan.

Masayoshi HarigaiTakako MiyamaeHideyuki HashimotoKosei UmetsuKatsuhisa YamashitaYoshikazu Nakaoka
Published in: Modern rheumatology (2023)
TCZ was effective and well tolerated in Japanese patients with GCA and may be an effective treatment option combined with glucocorticoids.
Keyphrases
  • giant cell
  • rheumatoid arthritis
  • clinical trial
  • study protocol
  • juvenile idiopathic arthritis
  • combination therapy